A Pilot Study of Lactofiltrum to Treat Atopic Dermatitis in Adults
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose is to study efficacy of Lactofiltrum in adult patients with atopic dermatitis.
Lactofiltrum consists of 85% of hidrolytic lignin and 15% of lactulose and acts as an
enterosorbent, which enables to enhance metabolism and elimination of endotoxins and to
normalize metabolic and immune processes. Additionally, lactulose stimulates Bifidobacterium
flora and in aggregate it could improve skin condition afflicted by atopic dermatitis.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Avva Rus, JSC
Collaborators:
Moscow Dermatovenerologic Clinical Dispensary № 1 Moscow State University of Medicine and Dentistry